Publications in collaboration with researchers from Hospital del Mar (1)

2013

  1. Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers

    BMC Neurology, Vol. 13